• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Economic analysis of gene expression profile data to guide adjuvant treatment in women with early-stage breast cancer.

作者信息

Cosler Leon E, Lyman Gary H

机构信息

Department of Pharmacy Practice, Albany College of Pharmacy and Health Sciences, Albany, New York 12208-3492, USA.

出版信息

Cancer Invest. 2009 Dec;27(10):953-9. doi: 10.3109/07357900903275217.

DOI:10.3109/07357900903275217
PMID:19909009
Abstract
摘要

相似文献

1
Economic analysis of gene expression profile data to guide adjuvant treatment in women with early-stage breast cancer.基因表达谱数据的经济分析以指导早期乳腺癌女性的辅助治疗。
Cancer Invest. 2009 Dec;27(10):953-9. doi: 10.3109/07357900903275217.
2
Genomic profile of breast cancer: cost-effectiveness analysis from the Spanish National Healthcare System perspective.乳腺癌的基因组概况：从西班牙国家医疗保健系统角度进行的成本效益分析。
Expert Rev Pharmacoecon Outcomes Res. 2014 Dec;14(6):889-99. doi: 10.1586/14737167.2014.957185. Epub 2014 Sep 12.
3
Assessing therapeutically developed assays.评估已开发用于治疗的检测方法。
Manag Care. 2008 Jul;17(7 Suppl 7):9-12; discussion 17-8.
4
Cost-effectiveness of 70-gene MammaPrint signature in node-negative breast cancer.70 基因 MammaPrint 检测在淋巴结阴性乳腺癌中的成本效益。
Am J Manag Care. 2010 Dec 1;16(12):e333-42.
5
Multigene classifiers, prognostic factors, and predictors of breast cancer clinical outcome.多基因分类器、乳腺癌临床结局的预后因素及预测指标。
Adv Anat Pathol. 2009 Jul;16(4):204-15. doi: 10.1097/PAP.0b013e3181a9d4bf.
6
Cancer is heterogeneous.癌症具有异质性。
J Clin Oncol. 2009 Jun 1;27(16):2732; author reply 2734-5. doi: 10.1200/JCO.2008.21.7646. Epub 2009 Apr 20.
7
Is adjuvant therapy for older patients with node (+) early breast cancer cost-effective?辅助治疗对老年淋巴结阳性早期乳腺癌患者是否具有成本效益？
Breast Cancer Res Treat. 2005 Nov;94(2):95-103. doi: 10.1007/s10549-004-8267-0.
8
Is immunohistochemistry less sensitive than quantitative reverse transcriptase polymerase chain reaction for hormone receptor status determination in breast cancer?在乳腺癌激素受体状态测定中，免疫组织化学是否比定量逆转录聚合酶链反应敏感性更低？
J Clin Oncol. 2009 Jun 1;27(16):2733; author reply 2734-5. doi: 10.1200/JCO.2009.22.0269. Epub 2009 Apr 20.
9
Gene expression profiles of breast cancer obtained from core cut biopsies before neoadjuvant docetaxel, adriamycin, and cyclophoshamide chemotherapy correlate with routine prognostic markers and could be used to identify predictive signatures.在新辅助多西他赛、阿霉素和环磷酰胺化疗前，通过粗针活检获得的乳腺癌基因表达谱与常规预后标志物相关，可用于识别预测性特征。
Zentralbl Gynakol. 2006 Apr;128(2):76-81. doi: 10.1055/s-2006-921508.
10
Cost-effectiveness of extended adjuvant letrozole therapy after 5 years of adjuvant tamoxifen therapy in postmenopausal women with early-stage breast cancer.他莫昔芬辅助治疗5年后，来曲唑延长辅助治疗对绝经后早期乳腺癌女性的成本效益分析。
Am J Manag Care. 2006 Jul;12(7):374-86.

引用本文的文献

1
Gene Expression Profiling Tests for Early-Stage Invasive Breast Cancer: A Health Technology Assessment.早期浸润性乳腺癌的基因表达谱检测：一项卫生技术评估
Ont Health Technol Assess Ser. 2020 Mar 6;20(10):1-234. eCollection 2020.
2
Economic Evaluations of Pharmacogenetic and Pharmacogenomic Screening Tests: A Systematic Review. Second Update of the Literature.药物遗传学和药物基因组学筛查试验的经济学评估：系统评价。文献的第二次更新
PLoS One. 2016 Jan 11;11(1):e0146262. doi: 10.1371/journal.pone.0146262. eCollection 2016.
3
Clinical utility of gene-expression profiling in women with early breast cancer: an overview of systematic reviews.
基因表达谱在早期乳腺癌女性中的临床应用：系统评价综述
Genet Med. 2015 Jul;17(7):519-32. doi: 10.1038/gim.2014.140. Epub 2014 Dec 4.
4
Far beyond the usual biomarkers in breast cancer: a review.远超越乳腺癌的常规生物标志物：综述。
J Cancer. 2014 Jul 4;5(7):559-71. doi: 10.7150/jca.8925. eCollection 2014.
5
Multigene assays and molecular markers in breast cancer: systematic review of health economic analyses.多基因检测与乳腺癌分子标志物：系统评价健康经济学分析。
Breast Cancer Res Treat. 2013 Jun;139(3):621-37. doi: 10.1007/s10549-013-2559-1. Epub 2013 May 31.
6
Adoption of gene expression profile testing and association with use of chemotherapy among women with breast cancer.采用基因表达谱检测与乳腺癌女性化疗应用的关联。
J Clin Oncol. 2012 Jun 20;30(18):2218-26. doi: 10.1200/JCO.2011.38.5740. Epub 2012 May 14.
7
Pharmacoeconomics of the myeloid growth factors: a critical and systematic review.骨髓生长因子的药物经济学：一项关键且系统的综述。
Pharmacoeconomics. 2012 Jun 1;30(6):497-511. doi: 10.2165/11590130-000000000-00000.
8
Economic evaluation of targeted cancer interventions: critical review and recommendations.针对癌症干预措施的经济评价：批判性回顾与建议。
Genet Med. 2011 Oct;13(10):853-60. doi: 10.1097/GIM.0b013e31821f3e64.